Abstract
The natural polyamines -putrescine, spermidine, and spermine- are essential for cell growth and differentiation. Polyamines are involved in several gene regulatory functions, although their mechanism(s) of action has not been elucidated. We investigated the role of polyamines in the function of NF-κB and estrogen receptor-α (ERα), two transcription factors implicated in breast cancer cell proliferation and cell survival, using MCF-7 breast cancer cells. We found that spermine facilitated the binding of ERα and NF-κB to estrogen response element (ERE)- and NF-κB response element (NRE), respectively, and enhanced ERα-mediated transcriptional activation in transient transfection experiments. We also found that the association of the co-regulatory protein CBP/p300 with ERα and NF-κB was increased by spermine treatment of MCF-7 cells. Spermine also increased the nuclear translocation of NF-κB compared to the control. In contrast, treatment of MCF-7 cells with polyamine analogs, BE-3-4-3 and BE-3-3-3, resulted in transcriptional inhibition of both ERE- and NRE-driven reporter plasmids. In addition, polyamine analogs inhibited the association of ERα and NF-κB with CBP/p300 and were unable to facilitate nuclear translocation of NF-κB. APO-BRDU assay demonstrated that polyamine analogs induced apoptosis, with a loss of the anti-apoptotic protein Bcl-2. These data show a gene regulatory function of polyamines involving transcriptional activation of ERα and NF-κB, potentially leading to the up-regulation of genes involved in breast cancer cell proliferation. Our results with BE-3-4-3 and BE-3-3-3 suggest that down-regulation of ERα- and NF-κB-regulated genes is a possible mechanism for the action of polyamine analogs in inducing apoptosis of breast cancer cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abraham SE, Lobo S, Yaciuk P, Wang HG, Moran E . 1993 Oncogene 8: 1639–1647
Baldwin Jr AS . 1996 Annu. Rev. Immunol. 14: 649–681
Baeurle PA, Baltimore D . 1996 Cell 87: 13–20
Beg AA, Baltimore D . 1996 Science 274: 782–784
Berchtold CM, Tamez P, Kensler TW, Casero Jr RA . 1998 J. Cell Physiol. 174: 380–386
Berger SL . 1999 Curr. Opin. Cell Biol. 11: 336–341
Berthois Y, Katzenellenbogen JA, Katzenellenbogen BS . 1986 Proc. Natl. Acad. Sci. USA 83: 2496–2500
Biswas DK, Cruz AP, Gansberger E, Pardee AB . 2000 Proc. Natl. Acad. Sci. USA 97: 8542–8547
Boland MP, O'Neill LA . 1998 J Biol Chem. 273: 15494–15500
Bradford MM . 1976 Anal. Biochem. 72: 248–254
Bryans M, Harley E, Gilmour SK . 1996 Biochem. Biophys. Res. Commun. 226: 618–625
Canizares F, Salinas J, de las Heras M, Diaz J, Tovar I, Martinez P, Penafiel R . 1999 Clin. Cancer Res. 5: 2035–2041
Carlotti F, Dower SK, Qwarnstrom EE . 2000 J. Biol. Chem. 275: 41028–41034
Casero Jr RA, Celano P, Ervin SJ, Porter CW, Bergeron RJ, Libby PR . 1989 Cancer Res. 49: 3829–3833
Casero RA, Pegg AE . 1993 FASEB J. 7: 653–661
Celano P, Baylin SB, Casero Jr RA . 1989 J. Biol. Chem. 264: 8922–8927
Cogswell PC, Guttridge DC, Funkhouser WK, Baldwin Jr AS . 2000 Oncogene 19: 1123–1131
Cohen SS . 1998 A Guide to the Polyamines Oxford University Press: New York
Chu ZL, McKinsey TA, Liu L, Gentry JJ, Malim MH, Ballard DW . 1997 Proc. Natl. Acad. Sci. USA 94: 10057–10062
Cusack Jr JC, Liu R, Baldwin Jr AS . 2000 Cancer Res. 60: 2323–2330
Davidson NE, Mank AR, Prestigiacomo LJ, Bergeron RJ, Casero Jr RA . 1993 Cancer Res. 53: 2071–2075
Davidson NE, Hahm HA, McCloskey DE, Woster PM, Casero Jr RA . 1999 Endoc. Relat. Cancer 6: 69–73
Davis RH, Morris DR, Coffino P . 1992 Microbiol. Rev. 56: 280–290
Delzenne NM, Kok N, Deloyer P, Dandrifosse G . 2000 J. Nutr. 130: 2456–2460
Doerre S, Corley RB . 1999 J. Immunol. 163: 269–277
Desiderio MA, Dansi P, Tacchini L, Bernelli-Zazzera A . 1999 FEBS Lett. 455: 149–153
Dong L, Wang W, Wang F, Stoner M, Reed JC, Harigai M, Samudio I, Kladde MP, Vyhlidal C, Safe S . 1999 J. Biol. Chem. 274: 32099–32107
Faaland CA, Laskin JD, Thomas TJ . 1995 Cell Growth Differ. 6: 115–121
Faaland CA, Thomas TJ, Mian S, Shirahata A, Gallo MA, Thomas T . 2000 Biochem. Cell Biol. 78: 415–426
Feuerstein BG, Pattabiraman N, Marton LJ . 1990 Nucleic Acids Res. 18: 1271–1282
Gabrielson EW, Pegg AE, Casero Jr RA . 1999 Clin. Cancer Res. 5: 1638–1641
Galien R, Garcia T . 1997 Nucleic Acids Res. 25: 2424–2429
Gerritsen ME, Williams AJ, Neish AS, Moore S, Shi Y, Collins T . 1997 Proc. Natl. Acad. Sci. USA 94: 2927–2932
Grumont RJ, Rourke IJ, Gerondakis S . 1999 Genes Dev. 13: 400–411
Guttridge D, Albanese CC, Reuther Y, Pestell RG, Baldwin Jr AS . 1999 Mol. Cell Biol. 19: 5785–5799
Ha HC, Woster PM, Yager JD, Casero Jr RA . 1997 Proc. Natl. Acad. Sci. USA 94: 11557–11562
Hanstein B, Eckner R, DiRenzo J, Halachmi S, Liu H, Searcy BR, Kurokawa R, Brown M . 1996 Proc. Natl. Acad. Sci. USA 93: 11540–11545
Harhaj EW, Sun SC . 1999 Mol. Cell Biol. 19: 7088–7095
Hibshoosh H, Johnson M, Weinstein IB . 1991 Oncogene 6: 739–743
Hinz M, Krappmann D, Eichten A, Heder A, Scheidereit C, Strauss M . 1999 Mol. Cell Biol. 19: 2690–2698
Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto S, Tung L . 1996 Mol. Endocrinol. 10: 1167–1177
Hu RH, Pegg AE . 1997 Biochem. J. 328: 307–316
Huang Y, Ray S, Reed JC, Ibrado AM, Tang C, Nawabi A, Bhalla K . 1997 Breast Cancer Res. Treat. 42: 73–81
Igarashi K, Koga K, He Y, Shimogori T, Ekimoto H, Kashiwagi K, Shirahata A . 1995 Cancer Res. 55: 2615–2619
Igarashi K, Kashiwagi K . 2000 Biochem Biophys Res Commun 271: 559–564
Imbert V, Rupec RA, Livolsi A, Pahl HL, Traenckner EB, Mueller-Dieckmann C, Farahifar D, Rossi B, Auberger P, Baeuerle PA, Peyron JF . 1996 Cell 86: 787–798
Katzenellenbogen JA, O'Malley BW, Katzenellenbogen BS . 1996 Mol. Endocrinol. 10: 119–131
Kee BL, Arias J, Montminy MR . 1996 J. Biol. Chem. 271: 2373–2375
Kim DW, Sovak MA, Zanieski G, Nonet G, Romieu-Mourez R, Lau AW, Hafer LJ, Yaswen P, Stampfer M, Rogers AE, Russo J, Sonenshein GE . 2000 Carcinogenesis 21: 871–879
Klinge CM, Silver BF, Driscoll MD, Sathya G, Bambara RA, Hilf R . 1997 J. Biol. Chem. 272: 31465–31474
Kramer DL, Fogel-Petrovic M, Diegelman P, Cooley JM, Bernacki RJ, McManis JS, Bergeron RJ, Porter CW . 1997 Cancer Res. 57: 5521–5527
Krappmann D, Scheidereit C . 1997 Immunobiology 198: 3–13
Kuo MH, Allis CD . 1998 Bioessays 20: 615–626
Kurebayashi S, Miyashita Y, Hirose T, Kasayama S, Akira S, Kishimoto T . 1997 J. Steroid Biochem. Mol. Biol. 60: 11–17
Leveque J, Bansard JY, Watier E, Catros-Quemener V, Havouis R, Moulinoux JP, Grall JY, Seiler N . 1999 Anticancer Res. 19: 2275–2279
Leveque J, Foucher F, Bansard JY, Havouis R, Grall JY, Moulinoux JP . 2000 Breast Cancer Res Treat. 60: 99–105
Manni A, Grove R, Kunselman S, Aldaz M . 1995 Cancer Lett. 92: 49–57
MacGregor JI, Jordan VC . 1998 Pharmacol. Rev. 50: 151–196
MacKichan ML, Logeat F, Israel A . 1996 J. Biol. Chem. 271: 6084–6091
Manni A, Grove R, Kunselman S, Aldaz M . 1995 Cancer Lett. 92: 49–57
Marton LJ, Pegg AE . 1995 Annu. Rev. Pharmacol. Toxicol. 35: 55–91
Matsushita H, Morishita R, Nata T, Aoki M, Nakagami H, Taniyama Y, Yamamoto K, Higaki J, Yasufumi K, Ogihara T . 2000 Circ. Res. 86: 974–978
Mayo MW, Wang CY, Cogswell PC, Rogers-Graham KS, Lowe SW, Der CJ, Baldwin Jr AS . 1997 Science 278: 1812–1815
McCloskey DE, Casero Jr RA, Woster PM, Davidson NE . 1995 Cancer Res. 55: 3233–3236
McCloskey DE, Yang J, Woster PM, Davidson NE, Casero Jr RA . 1996 Clin. Cancer Res. 2: 441–446
McKay LI, Cidlowski JA . 1998 Mol. Endocrinol. 12: 45–56
McKenna NJ, Lanz RB, O'Malley BW . 1999 Endocr. Rev. 20: 321–344
Munoz E, Courtois G, Veschambre V, Jalinot P, Israel A . 1994 J. Virol. 68: 8035–8044
Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet Jr RJ, Sledge Jr GW . 1997 Mol. Cell Biol. 17: 3629–3639
Newton TR, Patel NM, Bhat-Nakshatri P, Stauss CR, Goulet Jr RJ, Nakshatri H . 1999 J. Biol. Chem. 274: 18827–18835
O'Brien MJ, O'Keane JC, Zauber A, Gottlieb LS, Winawer SJ . 1992 Cancer 70: 1317–1327
O'Brien TG, Megosh LC, Gilliard G, Soler AP . 1997 Cancer Res. 57: 2630–2637
Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y . 1996 Cell 87: 953–959
Panagiotidis CA, Artandi S, Calame K, Silverstein SJ . 1995 Nucleic Acids Res. 23: 1800–1809
Pegg AE, McCann PP . 1982 Am. J. Physiol. 243: C212–C221
Pera PJ, Kramer DL, Sufrin JR, Porter CW . 1986 Cancer Res. 46: 1148–1154
Porter CW, Bergeron RJ . 1988 Adv. Exp. Med. Biol. 250: 677–690
Porter CW, Pegg AE, Ganis B, Madhubala R, Bergeron RJ . 1990 Biochem. J. 268: 207–212
Porter CW, Ganis B, Rustum Y, Wrzosek C, Kramer DL, Bergeron RJ . 1994 Cancer Res. 54:: 5917–5924
Rauch BH, Weber A, Braun M, Zimmermann N, Schror K . 2000 FEBS Lett. 481: 3–7
Rayet B, Gelinas C . 1999 Oncogene 18: 6938–6947
Reed JC, Miyashita T, Takayama S, Wang HG, Sato T, Krajewski S, Aime-Sempe C, Bodrug S, Kitada S, Hanada M . 1996 J. Cell Biochem. 60: 23–32
Rouet-Benzineb P, Gontero B, Dreyfus P, Lafuma C . 2000 J. Mol Cell Cardiol. 32: 1767–1778
Ryan KM, Ernst MK, Rice NR, Vousden KH . 2000 Nature 404: 892–897
Scalabrino G, Lorenzini EC . 1991 Mol. Cell Endocrinol. 7: 37–56
Schlegel A, Wang C, Katzenellenbogen BS, Pestell RG, Lisanti MP . 1999 J. Biol. Chem. 274: 33551–33556
Schorr K, Li M, Krajewski S, Reed JC, Furth PA . 1999 J. Mammary Gland Biol. Neoplasia 4: 153–164
Shah N, Thomas T, Shirahata A, Sigal LH, Thomas TJ . 1999 Biochemistry 38: 14763–14774
Sharma A, Glaves D, Porter CW, Raghavan D, Bernacki RJ . 1997 Clin. Cancer Res. 3: 1239–1244
Sheppard KA, Rose DW, Haque ZK, Kurokawa R, McInerney E, Westin S, Thanos D, Rosenfeld MG, Glass CK, Collins T . 1999 Mol. Cell Biol. 19: 6367–6978
Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM, Sonenshein GE . 1997 J. Clin. Invest. 100: 2952–2960
Siebenlist U, Franzoso G, Brown K . 1994 Annu. Rev. Cell Biol. 10: 405–455
Smith MK, Trempus CS, Gilmour SK . 1998 Carcinogenesis 19: 1409–1415
Stein B, Yang MX . 1995 Mol. Cell Biol. 15: 4971–4979
Tabib A, Bachrach U . 1994 Biochem. Biophys. Res. Commun. 202: 720–727
Tabib A, Bachrach U . 1999 Int. J. Biochem. Cell. Biol. 31: 1289–1295
Tabor CW, Tabor H . 1984 Annu. Rev. Biochem. 53: 749–790
Thomas TJ, Faaland CA, Adhikarakunnathu S, Watkins LF, Thomas T . 1998 Breast Cancer Res. Treat. 47: 181–193
Thomas T, Gallo MA, Klinge CM, Thomas TJ . 1995 J. Steroid Biochem. Mol. Biol. 54: 89–99
Thomas T, Kulkarni GD, Gallo MA, Greenfield N, Shirahata A, Lewis JS, Thomas TJ . 1997 Nucleic Acids Res. 25: 2396–2402
Thomas T, Shah N, Klinge CM, Faaland CA, Adikarakunnathu S, Gallo MA, Thomas TJ . 1999 J. Mol. Endocrinol. 22: 131–139
Thomas T, Thomas TJ . 1993 Breast Cancer Res. Treat. 29: 189–201
Thomas T, Thomas TJ . 2001 Cellu. Mol. Life Sci. 58: 244–258
Tremblay A, Tremblay GB, Labrie F, Giguere V . 1999 Mol. Cell 3: 513–519
Vanden Berghe W, De Bosscher K, Boone E, Plaisance S, Haegeman G . 1999 J. Biol. Chem. 274: 32091–32098
Wadgaonkar R, Phelps KM, Haque Z, Williams AJ., Silverman ES, Collins T . 1999 J. Biol. Chem. 274: 1879–1882
Wang CY, Cusack Jr JC, Liu R, Baldwin Jr AS . 1999 Nat. Med. 5: 412–417
Wang CY, Mayo MW, Baldwin Jr AS . 1996 Science 274: 784–787
Watanabe S, Kusama-Eguchi K, Kobayashi H, Igarashi K . 1991 J. Biol. Chem. 266: 20803–20809
Zhang GJ, Kimijima I, Onda M, Kanno M, Sato H, Watanabe T, Tsuchiya A, Abe R, Takenoshita S . 1999 Clin. Cancer Res. 5: 2971–2977
Zhang GJ, Kimijima I, Tsuchiya A, Abe R . 1998 Oncol. Rep. 5: 1211–1216
Zhong H, Voll RE, Ghosh S . 1998 Mol. Cell 1: 661–671
Zong WX, Edelstein LC, Chen C, Bash J, Gelinas C . 1999 Genes Dev. 13: 382–387
Acknowledgements
This work was supported by Public Health Service grants CA 42439, CA 73058, CA 80163 (T Thomas and TJ Thomas), DK 53220 (CM Kinge), Outstanding Breast Cancer Research Grant Awards from the NJ State Commission on Cancer Research (T Thomas and TJ Thomas), and a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture, Japan (A Shirahata).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shah, N., Thomas, T., Lewis, J. et al. Regulation of estrogenic and nuclear factor κB functions by polyamines and their role in polyamine analog-induced apoptosis of breast cancer cells. Oncogene 20, 1715–1729 (2001). https://doi.org/10.1038/sj.onc.1204247
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204247
Keywords
This article is cited by
-
Tamoxifen metabolite endoxifen interferes with the polyamine pathway in breast cancer
Amino Acids (2016)
-
A potential estrogen mimetic effect of a bis(ethyl)polyamine analogue on estrogen receptor positive MCF-7 breast cancer cells
Amino Acids (2012)
-
Spermine oxidase (SMO) activity in breast tumor tissues and biochemical analysis of the anticancer spermine analogues BENSpm and CPENSpm
BMC Cancer (2010)
-
Review of Molecular Biology of Human Cancers (An Advanced Student’s Text, by Wolfgang Schulz (Department of Urology and Center for Biological and Medical Research, Heinrich Heine University, Düsseldorf) ISBN 1-4020-3185-8
Apoptosis (2005)
-
Down-regulation of Bcl-2 enhances estrogen apoptotic action in long-term estradiol-depleted ER+ breast cancer cells
Apoptosis (2005)